Abstract
Objectives
To describe the first clinical implantation of the CorNeat™ keratoprosthesis, which utilizes a polymeric scaffold for biointegration within ocular tissue.
Methods
The CorNeat keratoprosthesis was implanted in the right eye of a patient with bilateral corneal opacification and neovascularization secondary to multiple failed grafts. The following surgical technique was used: 360 degree peritomy; epithelial scraping and corneal marking; pre-placement of three corneo-scleral sutures through the implant; central trephination using a 7 mm trephine and host cornea removal; keratoprosthesis placement and sutures tightening while fitting the corneal edge into the posterior groove of the CorNeat keratoprosthesis; and repositioning of the conjunctiva over the implant skirt and fixation with sutures and Fibrin sealant.
Results
Twelve months postoperatively visual acuity improved to 1/16 from hand movement. The keratoprosthesis was properly positioned. Tactile intraocular pressure was assessed as normal. Regional, mostly nasal, conjunctival retraction of 4–5 mm over the nano-fibre skirt was seen throughout follow-up. The anterior chamber was quiet and well-formed. No other postoperative complications were observed.
Conclusion
This initial case may imply a potential breakthrough in the treatment of corneal disease not amenable to standard corneal transplant. Long follow-up and additional implantations are desired to prove the long-term safety and efficacy of this device.
Similar content being viewed by others
Data availability
All data generated in this case are included in this published article.
References
Avadhanam VS, Smith HE, Liu C. Keratoprostheses for corneal blindness: a review of contemporary devices. Clin Ophthalmol (Auckl, N. Z). 2015;9:697–720.
Mathews PM, Lindsley K, Aldave AJ, Akpek EK. Etiology of global corneal blindness and current practices of corneal transplantation: a focused review. Cornea 2018;37:1198–203.
Gain P, Jullienne R, He Z, Aldossary M, Acquart S, Cognasse F, et al. Global survey of corneal transplantation and eye banking. JAMA Ophthalmol. 2016;134:167–73.
Hicks C, Crawford G, Chirila T, Wiffen S, Vijayasekaran S, Lou X, et al. Development and clinical assessment of an artificial cornea. Prog retinal eye Res. 2000;19:149–70.
Crawford GJ, Hicks CR, Lou X, Vijayasekaran S, Tan D, Mulholland B, et al. The Chirila Keratoprosthesis: phase I human clinical trial. Ophthalmology 2002;109:883–9.
Hicks CR, Crawford GJ. Melting after keratoprosthesis implantation: the effects of medroxyprogesterone. Cornea 2003;22:497–500.
Hicks CR, Crawford GJ, Dart JKG, Grabner G, Holland EJ, Stulting RD, et al. AlphaCor: clinical outcomes. Cornea 2006;25:1034–42.
Ilhan-Sarac O, Akpek EK. Current concepts and techniques in keratoprosthesis. Curr Opin Ophthalmol. 2005;16:246–50.
Chirila TV, Hicks CR. The origins of the artificial cornea: Pellier de Quengsy and his contribution to the modern concept of keratoprosthesis. Gesnerus 1999;56:96–106.
Nonpassopon M, Niparugs M, Cortina MS. Boston type 1 keratoprosthesis: updated perspectives. Clin Ophthalmol (Auckl, N. Z). 2020;14:1189–1200.
Lee R, Khoueir Z, Tsikata E, Chodosh J, Dohlman CH, Chen TC. Long-term visual outcomes and complications of boston keratoprosthesis type II implantation. Ophthalmology 2017;124:27–35.
Sayegh RR, Avena Diaz L, Vargas-Martín F, Webb RH, Dohlman CH, Peli E. Optical functional properties of the boston keratoprosthesis. Investigative Opthalmology Vis Sci. 2010;51:857–63.
Aravena C, Yu F, Aldave AJ. Long-term visual outcomes, complications, and retention of the Boston Type I keratoprosthesis. Cornea 2018;37:3–10.
Jirásková N, Rozsival P, Burova M, Kalfertova M. AlphaCor artificial cornea: clinical outcome. Eye 2011;25:1138–46.
Basu S, Serna-Ojeda JC, Senthil S, Pappuru RR, Bagga B, Sangwan V. The Aurolab Keratoprosthesis (KPro) versus the Boston Type I Kpro: 5-year clinical outcomes in 134 cases of bilateral corneal blindness. Am J Ophthalmol. 2019;205:175–83.
de la Paz MF, Salvador-Culla B, Charoenrook V, Temprano J, Álvarez de Toledo J, Grabner G, et al. Osteo-odonto-, Tibial bone and Boston keratoprosthesis in clinically comparable cases of chemical injury and autoimmune disease. Ocul Surf. 2019;17:476–83.
Liu C, Paul B, Tandon R, Lee E, Fong K, Mavrikakis I, et al. The osteo-odonto-keratoprosthesis (OOKP). Semin Ophthalmol. 2005;20:113–28.
Litvin G, Klein I, Litvin Y, Klaiman G, Nyska A. CorNeat KPro: ocular implantation study in rabbits. Cornea 2021;40:1165–74.
Cordeiro MF, Chang L, Lim KS, Daniels JT, Pleass RD, Siriwardena D, et al. Modulating conjunctival wound healing. Eye 2000;14:536–47.
Karatepe C, Altinay L, Yetim TD, Dagli C, Dursun S. A novel electrospun nano-fabric graft allows early cannulation access and reduces exposure to central venous catheters. The J Vasc Access. 2013;14:273–80.
Ferraresso M, Bortolani EM, Amnon G. A two-year experience with a rapid access, self-sealing, polycarbonate urethane nanofiber vascular access graft for hemodialysis. J Vasc Access. 2016;17:210–4.
Funding
The study was funded by CorNeat Vision Ltd.
Author information
Authors and Affiliations
Contributions
GL designed the model and the study framework. IB and EL performed the described experiment. All authors analysed the data. OR and IB wrote the manuscript. All authors provided critical feedback and helped shape the experiment, analysis and manuscript.
Corresponding author
Ethics declarations
Competing interests
GL is an employee of CorNeat Vision Ltd and the inventor of the Corneat Kpro. No other author has any financial or proprietary interest in any material or method mentioned
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Bahar, I., Reitblat, O., Livny, E. et al. The first-in-human implantation of the CorNeat keratoprosthesis. Eye 37, 1331–1335 (2023). https://doi.org/10.1038/s41433-022-02105-3
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41433-022-02105-3
- Springer Nature Limited